PRIMECAP MANAGEMENT CO CA
Q4 2022 Form 13-F
PASADENA, CALIFORNIA
CIK 0000763212
· CRD 105516
· SEC-registered investment adviser
$109.2B Reported Value Total
PRIMECAP MANAGEMENT CO reports 37 total accounts under management (AUM). There are 37 discretionary accounts valued at $117,232,900,412, and 0 non-discretionary accounts.
Source: Form ADV filed * Note that certain holdings are exempt from Form 13-F reporting, so the AUM totals may be greater than the Form 13-F total.
Source: Form ADV filed 2026-07-29
Reported value
$109.2B
Quarter over quarter
+9.3%
Holdings
334
Top-10 concentration
33.0%
Key People
Form ADV owners & control persons
Joel Paul Fried
CHAIRMAN
Mohammed Mohsin Ansari
VICE CHAIRMAN
Theofanis A Kolokotrones
CHAIRMAN EMERITUS
Filing Navigation
Coverage begins with the second quarter of 2013. Earlier quarters are not shown while their accuracy is being verified.
13F Metrics
Loading 13F Metrics
Q4 2022 13F record
Q4 2022 13F filing summary
| Period of report | December 31, 2022 |
|---|---|
| Filed | February 13, 2023 |
| Form | 13F-HR |
| Reported value | $109.2B |
| Positions | 334 |
| Change in reported value | +5.7% |
| New positions | 9 |
| Exited positions | 10 |
| Position turnover | 5.5% |
| Top-10 concentration | 33.0% |
13F filings by quarter
| Quarter | Positions | Value |
|---|---|---|
|
Q2 2026 13F
Filed Aug 14, 2026
|
324 | $169.1B |
|
Q1 2026 13F
Filed May 11, 2026
|
320 | $127.0B |
|
Q4 2025 13F
Filed Feb 11, 2026
|
319 | $132.1B |
|
Q3 2025 13F
Filed Nov 12, 2025
|
327 | $130.6B |
|
Q2 2025 13F
Filed Aug 11, 2025
|
333 | $126.2B |
|
Q1 2025 13F
Filed May 9, 2025
|
335 | $121.0B |
|
Q4 2024 13F
Filed Feb 10, 2025
|
329 | $129.1B |
|
Q3 2024 13F
Filed Nov 8, 2024
|
336 | $136.0B |
|
Q2 2024 13F
Filed Aug 9, 2024
|
332 | $138.1B |
|
Q1 2024 13F
Filed May 14, 2024
|
335 | $134.1B |
|
Q4 2023 13F
Filed Feb 9, 2024
|
334 | $126.3B |
|
Q3 2023 13F
Filed Nov 13, 2023
|
331 | $118.5B |
|
Q2 2023 13F
Filed Aug 11, 2023
|
328 | $119.7B |
|
Q1 2023 13F
Filed May 15, 2023
|
331 | $114.7B |
|
Q4 2022 13F
Filed Feb 13, 2023
|
334 | $109.2B |
|
Q3 2022 13F
Filed Nov 14, 2022
|
335 | $103.3B |
|
Q2 2022 13F
Filed Aug 11, 2022
|
341 | $111.9B |
|
Q1 2022 13F
Filed May 11, 2022
|
339 | $132.6B |
|
Q4 2021 13F
Filed Feb 11, 2022
|
342 | $144.5B |
|
Q3 2021 13F
Filed Nov 12, 2021
|
337 | $141.7B |
33 earlier quarters on file — choose one from the quarter menu above.
Top 20 holdings · Q4 2022
| # | Holding | Reported value | % of portfolio |
|---|---|---|---|
| 1 | LLY LILLY ELI & CO | $9.5B | 8.67% |
| 2 | BIIB BIOGEN INC | $4.3B | 3.98% |
| 3 | AMGN AMGEN INC | $4.0B | 3.68% |
| 4 | MSFT MICROSOFT CORP | $3.2B | 2.92% |
| 5 | AZN ASTRAZENECA PLC | $3.1B | 2.79% |
| 6 | TXN TEXAS INSTRS INC | $2.8B | 2.58% |
| 7 | KLAC KLA CORP | $2.6B | 2.34% |
| 8 | FDX FEDEX CORP | $2.4B | 2.21% |
| 9 | ADBE ADOBE SYSTEMS INCORPORATED | $2.1B | 1.95% |
| 10 | TMO THERMO FISHER SCIENTIFIC INC | $2.0B | 1.84% |
| 11 | MU MICRON TECHNOLOGY INC | $2.0B | 1.82% |
| 12 | WFC WELLS FARGO CO NEW | $2.0B | 1.8% |
| 13 | GOOGL ALPHABET INC | $1.9B | 1.7% |
| 14 | SONY SONY GROUP CORPORATION | $1.9B | 1.7% |
| 15 | BMRN BIOMARIN PHARMACEUTICAL INC | $1.8B | 1.67% |
| 16 | LUV SOUTHWEST AIRLS CO | $1.8B | 1.61% |
| 17 | BSX BOSTON SCIENTIFIC CORP | $1.7B | 1.59% |
| 18 | BMY BRISTOL-MYERS SQUIBB CO | $1.6B | 1.44% |
| 19 | NVS NOVARTIS AG | $1.6B | 1.43% |
| 20 | BABA ALIBABA GROUP HLDG LTD | $1.5B | 1.39% |
Values as reported on the Q4 2022 Form 13F. Every position is in the holdings table below.